Study of QLS1410 in the Treatment of Primary Aldosteronism.
Clinical trial NCT07550465 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07550465
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2027-04-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.